Search

everythinglearnresearchcommunity

for

Search:↓

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Some herbs show promise as antiandrogenic agents.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride effectively treats hair loss in transgender men with few side effects.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Men can report their own balding patterns well enough for large health studies.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Higher aldosterone levels link to hair loss and high blood pressure.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.